ReviewCell communication and signaling : CCS2026
The aberration of key amino acids participated one-carbon metabolism may jeopardize genetic stability in cancer development.
Review in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
One-carbon (1C) metabolism, primarily orchestrated by key amino acids, serves as a fundamental biochemical hub that sustains diverse physiological functions, especially genetic stability. Given the indispensable role of 1C units in providing building blocks, redox donors, and methyl donors for genomic integrity, deficiencies in 1C-associated amino acids have been proposed to disrupt genome maintenance and potentially promote oncogenic alterations. Such disruptions are suggested to create a permissive environment for oncogenesis, driving epigenetic chaos and gene mutations, which may in turn exacerbate metabolic imbalance. This review comprehensively summarizes the multifaceted roles of 1C metabolism in cellular physiology, with a focus on its function in nucleotide and protein biosynthesis, integrated maintenance of redox equilibrium, and methylation-dependent chromatin remodeling. Special emphasis is placed on elucidating the genetic-level mechanisms through which 1C metabolism influences cancer initiation and progression. Based on systematic analysis of these interconnected pathways, we highlight how dysregulation of 1C metabolism contributes to tumorigenesis, especially through impaired nucleotide synthesis and compromised DNA integrity. Finally, we discuss the emerging therapeutic potential of targeting 1C metabolic pathways in cancer, particularly from the perspective of restoring genomic stability.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.